Future studies incorporating longitudinal follow‐up, detailed lifestyle profiling, and multi‐center comparisons across diverse populations will be essential to clarify the independent impact of CagA status and subtypes, and to validate the clinical utility of the ABC method in broader gastric cancer screening programs. The gene discussed is S100A8; the disease is gastric cancer.